Prowess-shock trial: a protocol overview and perspectives

Sepsis remains a challenge for intensive care physicians, as it keeps up with high mortality rate in spite of the high costs associated with its treatment. Several studies indicate that the infusion of Drotrecogin-alpha activated (DrotAA) reduce mortality in patients at high risk of death when admin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Shock (Augusta, Ga.) Ga.), 2010-09, Vol.34 Suppl 1 (7), p.48-53
Hauptverfasser:	Silva, Eliézer, de Figueiredo, Luiz Francisco Poli, Colombari, Fernando
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Animals APACHE Blood Coagulation Factors - metabolism Clinical Protocols Double-Blind Method Europe Fibrinolysis Health Promotion Humans Inflammation International Cooperation Multicenter Studies as Topic - methods Multicenter Studies as Topic - statistics & numerical data Multiple Organ Failure - drug therapy Multiple Organ Failure - etiology Multiple Organ Failure - mortality Protein C - adverse effects Protein C - therapeutic use Randomized Controlled Trials as Topic - methods Randomized Controlled Trials as Topic - statistics & numerical data Recombinant Proteins - adverse effects Recombinant Proteins - therapeutic use Research Design Shock, Septic - drug therapy Shock, Septic - mortality Thrombophilia - drug therapy Thrombophilia - etiology Thrombophilia - physiopathology United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!